$NYMX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NYMOX PHARMACEUTICAL CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NYMOX PHARMACEUTICAL CORP. Get notifications about new insider transactions in NYMOX PHARMACEUTICAL CORP for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.33 | 1,000 | 3,330 | 3,115,550 | 3.1 M to 3.1 M (+0.03 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.32 | 500 | 1,660 | 3,114,550 | 3.1 M to 3.1 M (+0.02 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.31 | 100 | 331 | 3,114,050 | 3.1 M to 3.1 M (0.00 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.30 | 200 | 660 | 3,113,950 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.29 | 100 | 329 | 3,113,750 | 3.1 M to 3.1 M (0.00 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.28 | 100 | 328 | 3,113,650 | 3.1 M to 3.1 M (0.00 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.26 | 100 | 326 | 3,113,550 | 3.1 M to 3.1 M (0.00 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.25 | 5,600 | 18,222 | 3,113,450 | 3.1 M to 3.1 M (+0.18 %) |
| Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.25 | 300 | 975 | 3,107,850 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.18 | 5,374 | 17,103 | 3,107,550 | 3.1 M to 3.1 M (+0.17 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 200 | 635 | 3,102,176 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 300 | 951 | 3,101,976 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 100 | 317 | 3,101,676 | 3.1 M to 3.1 M (0.00 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 68 | 215 | 3,101,576 | 3.1 M to 3.1 M (0.00 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 158 | 500 | 3,101,508 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 800 | 2,532 | 3,101,350 | 3.1 M to 3.1 M (+0.03 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.42 | 4,900 | 16,758 | 3,100,550 | 3.1 M to 3.1 M (+0.16 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.38 | 100 | 338 | 3,095,650 | 3.1 M to 3.1 M (0.00 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.37 | 500 | 1,685 | 3,095,550 | 3.1 M to 3.1 M (+0.02 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.36 | 900 | 3,024 | 3,095,050 | 3.1 M to 3.1 M (+0.03 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.35 | 1,000 | 3,350 | 3,094,150 | 3.1 M to 3.1 M (+0.03 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.31 | 600 | 1,986 | 3,093,150 | 3.1 M to 3.1 M (+0.02 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.30 | 100 | 330 | 3,092,550 | 3.1 M to 3.1 M (0.00 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.29 | 1,400 | 4,606 | 3,092,450 | 3.1 M to 3.1 M (+0.05 %) |
| Feb 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.28 | 500 | 1,640 | 3,091,050 | 3.1 M to 3.1 M (+0.02 %) |
| Feb 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.47 | 5,000 | 17,350 | 3,090,550 | 3.1 M to 3.1 M (+0.16 %) |
| Jan 22 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.14 | 3,000 | 9,415 | 3,085,550 | 3.1 M to 3.1 M (+0.10 %) |
| Aug 04 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.67 | 5,000 | 18,350 | 3,082,550 | 3.1 M to 3.1 M (+0.16 %) |
| Aug 04 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.79 | 5,000 | 18,950 | 3,077,550 | 3.1 M to 3.1 M (+0.16 %) |
| Aug 01 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.67 | 5,000 | 18,350 | 3,072,550 | 3.1 M to 3.1 M (+0.16 %) |
| Aug 01 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.72 | 5,000 | 18,600 | 3,067,550 | 3.1 M to 3.1 M (+0.16 %) |
| Aug 01 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.77 | 5,000 | 18,850 | 3,062,550 | 3.1 M to 3.1 M (+0.16 %) |
| Jul 07 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.13 | 2,500 | 10,325 | 3,057,550 | 3.1 M to 3.1 M (+0.08 %) |
| Jul 07 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.09 | 1,000 | 4,090 | 3,055,050 | 3.1 M to 3.1 M (+0.03 %) |
| Jul 07 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.93 | 1,500 | 5,895 | 3,054,050 | 3.1 M to 3.1 M (+0.05 %) |
| Jul 07 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.92 | 1,000 | 3,920 | 3,052,550 | 3.1 M to 3.1 M (+0.03 %) |
| Jul 07 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.91 | 500 | 1,955 | 3,051,550 | 3.1 M to 3.1 M (+0.02 %) |
| Jul 07 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.99 | 1,500 | 5,985 | 3,051,050 | 3 M to 3.1 M (+0.05 %) |
| Jul 07 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.97 | 2,000 | 7,940 | 3,049,550 | 3 M to 3 M (+0.07 %) |
| Jul 07 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.95 | 1,000 | 3,950 | 3,047,550 | 3 M to 3 M (+0.03 %) |
| Jul 07 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.94 | 500 | 1,970 | 3,046,550 | 3 M to 3 M (+0.02 %) |
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.02 | 2,000 | 8,040 | 3,046,050 | 3 M to 3 M (+0.07 %) |
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.01 | 1,000 | 4,010 | 3,044,050 | 3 M to 3 M (+0.03 %) |
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.00 | 500 | 2,000 | 3,043,050 | 3 M to 3 M (+0.02 %) |
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.16 | 2,000 | 8,320 | 3,042,550 | 3 M to 3 M (+0.07 %) |
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.15 | 500 | 2,075 | 3,040,550 | 3 M to 3 M (+0.02 %) |
| Jun 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.14 | 2,500 | 10,350 | 3,040,050 | 3 M to 3 M (+0.08 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.07 | 500 | 2,035 | 3,037,550 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.05 | 500 | 2,025 | 3,037,050 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.04 | 1,000 | 4,040 | 3,036,550 | 3 M to 3 M (+0.03 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.00 | 1,500 | 6,000 | 3,035,550 | 3 M to 3 M (+0.05 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.92 | 1,000 | 3,920 | 3,034,050 | 3 M to 3 M (+0.03 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.91 | 500 | 1,955 | 3,033,050 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.74 | 900 | 3,366 | 3,032,550 | 3 M to 3 M (+0.03 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.73 | 600 | 2,238 | 3,031,650 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.65 | 500 | 1,825 | 3,031,050 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.59 | 1,000 | 3,590 | 3,030,550 | 3 M to 3 M (+0.03 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.58 | 500 | 1,790 | 3,029,550 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.57 | 500 | 1,785 | 3,029,050 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.56 | 600 | 2,136 | 3,028,550 | 3 M to 3 M (+0.02 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.55 | 400 | 1,420 | 3,027,950 | 3 M to 3 M (+0.01 %) |
| Jun 26 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.77 | 5,000 | 18,850 | 3,027,550 | 3 M to 3 M (+0.17 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.77 | 1,000 | 3,770 | 3,022,550 | 3 M to 3 M (+0.03 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.76 | 3,500 | 13,160 | 3,021,550 | 3 M to 3 M (+0.12 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.75 | 500 | 1,875 | 3,018,050 | 3 M to 3 M (+0.02 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.79 | 500 | 1,895 | 3,017,550 | 3 M to 3 M (+0.02 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.77 | 2,200 | 8,294 | 3,017,050 | 3 M to 3 M (+0.07 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.76 | 300 | 1,128 | 3,014,850 | 3 M to 3 M (+0.01 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.75 | 2,000 | 7,500 | 3,014,550 | 3 M to 3 M (+0.07 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.80 | 1,900 | 7,220 | 3,012,550 | 3 M to 3 M (+0.06 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.79 | 2,000 | 7,580 | 3,010,650 | 3 M to 3 M (+0.07 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.78 | 500 | 1,890 | 3,008,650 | 3 M to 3 M (+0.02 %) |
| Jun 21 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.77 | 600 | 2,262 | 3,008,150 | 3 M to 3 M (+0.02 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.90 | 2,500 | 9,750 | 3,007,550 | 3 M to 3 M (+0.08 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.86 | 1,800 | 6,948 | 3,005,050 | 3 M to 3 M (+0.06 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.85 | 2,200 | 8,470 | 3,003,250 | 3 M to 3 M (+0.07 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.82 | 3,500 | 13,370 | 3,001,050 | 3 M to 3 M (+0.12 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.87 | 1,500 | 5,805 | 2,997,550 | 3 M to 3 M (+0.05 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.83 | 10,000 | 38,300 | 2,996,050 | 3 M to 3 M (+0.33 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.82 | 6,200 | 23,684 | 2,986,050 | 3 M to 3 M (+0.21 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.81 | 7,800 | 29,718 | 2,979,850 | 3 M to 3 M (+0.26 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.80 | 3,970 | 15,086 | 2,972,050 | 3 M to 3 M (+0.13 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.79 | 2,110 | 7,997 | 2,968,080 | 3 M to 3 M (+0.07 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.77 | 120 | 452 | 2,965,970 | 3 M to 3 M (0.00 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.76 | 4,500 | 16,920 | 2,965,850 | 3 M to 3 M (+0.15 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.75 | 3,800 | 14,250 | 2,961,350 | 3 M to 3 M (+0.13 %) |
| May 31 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.78 | 4,500 | 17,010 | 49,550 | 45.1 K to 49.6 K (+9.99 %) |
| Mar 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.60 | 43,848 | 157,853 | 2,957,550 | 2.9 M to 3 M (+1.50 %) |
| Mar 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.59 | 110 | 395 | 2,913,702 | 2.9 M to 2.9 M (0.00 %) |
| Mar 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.58 | 900 | 3,222 | 2,913,592 | 2.9 M to 2.9 M (+0.03 %) |
| Mar 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.57 | 100 | 357 | 2,912,692 | 2.9 M to 2.9 M (0.00 %) |
| Mar 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.54 | 900 | 3,186 | 2,912,592 | 2.9 M to 2.9 M (+0.03 %) |
| Mar 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.53 | 114 | 402 | 2,911,692 | 2.9 M to 2.9 M (0.00 %) |
| Mar 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.50 | 3,500 | 12,250 | 2,911,578 | 2.9 M to 2.9 M (+0.12 %) |
| Mar 29 2017 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.49 | 528 | 1,843 | 2,906,078 | 2.9 M to 2.9 M (+0.02 %) |
| Aug 12 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.47 | 500 | 1,235 | 2,907,550 | 2.9 M to 2.9 M (+0.02 %) |
| Aug 05 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.21 | 1,000 | 3,210 | 2,907,050 | 2.9 M to 2.9 M (+0.03 %) |
| Aug 05 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.29 | 1,000 | 3,290 | 2,906,050 | 2.9 M to 2.9 M (+0.03 %) |
| Aug 05 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.34 | 2,500 | 8,350 | 2,905,050 | 2.9 M to 2.9 M (+0.09 %) |
| Aug 05 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.60 | 2,500 | 9,000 | 2,902,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.62 | 2,500 | 9,050 | 2,900,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.63 | 2,500 | 9,075 | 2,897,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.70 | 2,500 | 9,250 | 2,895,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.80 | 2,500 | 9,500 | 2,892,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.89 | 2,500 | 9,725 | 2,890,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.98 | 2,500 | 9,950 | 2,887,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.03 | 2,500 | 10,075 | 2,885,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.10 | 2,500 | 10,250 | 2,882,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.02 | 2,500 | 10,050 | 2,880,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.41 | 2,500 | 8,525 | 2,877,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.35 | 2,500 | 8,375 | 2,875,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.27 | 2,500 | 8,175 | 2,872,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.29 | 2,500 | 8,225 | 2,870,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.41 | 2,500 | 8,525 | 2,877,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.35 | 2,500 | 8,375 | 2,875,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.27 | 2,500 | 8,175 | 2,872,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.29 | 2,500 | 8,225 | 2,870,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.20 | 2,500 | 8,000 | 2,867,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 4,089 | 12,962 | 2,865,050 | 2.9 M to 2.9 M (+0.14 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.21 | 911 | 2,924 | 2,860,961 | 2.9 M to 2.9 M (+0.03 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.20 | 2,500 | 8,000 | 2,860,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.33 | 2,500 | 8,325 | 2,857,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.33 | 2,500 | 8,325 | 2,855,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.41 | 2,500 | 8,525 | 2,852,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.43 | 2,500 | 8,575 | 2,850,050 | 2.8 M to 2.9 M (+0.09 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.36 | 1,500 | 5,040 | 2,847,550 | 2.8 M to 2.8 M (+0.05 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.45 | 3,000 | 10,350 | 2,846,050 | 2.8 M to 2.8 M (+0.11 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.71 | 2,500 | 9,275 | 2,843,050 | 2.8 M to 2.8 M (+0.09 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.74 | 3,500 | 13,090 | 2,840,550 | 2.8 M to 2.8 M (+0.12 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.40 | 2,500 | 8,500 | 2,837,050 | 2.8 M to 2.8 M (+0.09 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.45 | 1,500 | 5,175 | 2,834,550 | 2.8 M to 2.8 M (+0.05 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.42 | 3,000 | 10,260 | 2,833,050 | 2.8 M to 2.8 M (+0.11 %) |
| Jun 24 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.13 | 2,500 | 7,825 | 2,830,050 | 2.8 M to 2.8 M (+0.09 %) |
| Jun 24 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.03 | 2,500 | 7,575 | 2,827,550 | 2.8 M to 2.8 M (+0.09 %) |
| Jun 24 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.06 | 2,500 | 7,650 | 2,825,050 | 2.8 M to 2.8 M (+0.09 %) |
| Jun 24 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.88 | 2,500 | 7,200 | 2,822,550 | 2.8 M to 2.8 M (+0.09 %) |
| Jun 24 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.88 | 2,500 | 7,200 | 2,820,050 | 2.8 M to 2.8 M (+0.09 %) |
| Jun 24 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.92 | 2,500 | 7,300 | 2,817,550 | 2.8 M to 2.8 M (+0.09 %) |
| Jun 24 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.95 | 2,500 | 7,375 | 2,815,050 | 2.8 M to 2.8 M (+0.09 %) |
| Jun 24 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.85 | 2,500 | 7,125 | 2,812,550 | 2.8 M to 2.8 M (+0.09 %) |
| Jun 24 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.02 | 2,500 | 7,550 | 2,810,050 | 2.8 M to 2.8 M (+0.09 %) |
| May 13 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.31 | 5,000 | 11,550 | 2,807,550 | 2.8 M to 2.8 M (+0.18 %) |
| May 13 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.33 | 3,000 | 6,990 | 2,802,550 | 2.8 M to 2.8 M (+0.11 %) |
| May 13 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.35 | 2,500 | 5,875 | 2,799,550 | 2.8 M to 2.8 M (+0.09 %) |
| May 13 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.36 | 2,500 | 5,900 | 2,797,050 | 2.8 M to 2.8 M (+0.09 %) |
| May 13 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.32 | 2,500 | 5,800 | 2,794,550 | 2.8 M to 2.8 M (+0.09 %) |
| May 13 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.29 | 2,500 | 5,725 | 2,792,050 | 2.8 M to 2.8 M (+0.09 %) |
| May 13 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.28 | 2,000 | 4,560 | 2,789,550 | 2.8 M to 2.8 M (+0.07 %) |
| May 13 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.29 | 5,000 | 11,450 | 2,787,550 | 2.8 M to 2.8 M (+0.18 %) |
| May 13 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.32 | 3,010 | 6,983 | 2,782,550 | 2.8 M to 2.8 M (+0.11 %) |